The Xper Information Management is Philips’ new personalized cardiovascular workflow solution. The product suite ...
Weighing less than 20 pounds, the MyLab30 CV ultrasound system is the first compact ultrasound system to deliver premium ...
The Infinix VF-i/SP X-ray system is a universal cardiovascular system designed to accommodate diagnostic and ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
ZOLL Medical Corp. has received FDA clearance to market and sell the ZOLL M Series with Real CPR Help technology. The ...
Cordis Corp. recently introduced the REGATTA Steerable Guidewire family of devices in the U.S., which 12 selections of ...
May 9 — Brookwood Pharmaceuticals, Inc. and Targeted Technology Ventures LLC have announced the creation of a ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
z.one, the first convertible ultrasound system, provides the flexibility to instantly convert from a full-featured, cart ...
Immersion Medical has updated its endovascular platform with features that allow it to simulate a wider range of ...
MedicalCV Inc. has received FDA clearance for its SOLAR Surgical Ablation System for the ablation of soft tissue. The ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
The TURBO elite product line for excimer laser ablation is comercially available to treat peripheral artery disease (PAD). The line features an enhanced outer jacket and inner guide wire lumen with optimized ablation efficiency and energy output that enables increased penetration rates.
May 9, 2007 — Biosense Webster Inc., a worldwide leader in cardiac mapping and ablation, and Medtronic Inc., world leader in implanted cardiac rhythm devices, have announced plans to collaborate on a clinical trial, educational initiatives and a product development program, all of which are aimed at advancing the care of patients with cardiac arrhythmias, also known as irregular heartbeats.

When it comes to treating patients suffering from heart failure, which is typically defined as a heart whose pumping power is weaker than normal, physicians are facing a paradox.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...

If the cardiologists at the University of Mississippi Medical Center (UMC) in Jackson have been facing an uphill battle ...

Examples of physicians’ declining use of drug-eluting stents are growing. According to Dr. Louis Cannon, Cardiac & ...
May 8, 2007 - OBS Medical and Physio-Control Inc., a wholly-owned subsidiary of Medtronic Inc., announced they have ...